Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

HKG:8329 Revenue

Shenzhen Neptunus Interlong Bio-technique Company had revenue of 247.96M CNY in the quarter ending June 30, 2025, a decrease of -6.14%. This brings the company's revenue in the last twelve months to 993.11M, down -5.76% year-over-year. In the year 2024, Shenzhen Neptunus Interlong Bio-technique Company had annual revenue of 1.04B, down -2.18%.

• Revenue (ttm): 993.11M CNY
• Revenue Growth: -5.76%
• P/S Ratio: 0.25
• Revenue / Employee: 673.75K CNY
• Employees: 1,474
• Market Cap: 266.80M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.04B	-23.16M	-2.18%
Dec 31, 2023	1.06B	78.17M	7.92%
Dec 31, 2022	986.69M	147.89M	17.63%
Dec 31, 2021	838.81M	-192.56M	-18.67%
Dec 31, 2020	1.03B	-49.50M	-4.58%